211 related articles for article (PubMed ID: 36518628)
61. Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer.
Xue S; Shen K; Wang K; Ge W; Mao T; Li S; Zhang X; Xu H; Wang Y; Yao J; Yue M; Ma J; Wang Y; Shentu D; Cui J; Wang L
Dis Markers; 2022; 2022():5634887. PubMed ID: 36618967
[TBL] [Abstract][Full Text] [Related]
62. Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes.
Cui Y; Yuan Q; Chen J; Jiang J; Guan H; Zhu R; Li N; Liu W; Wang C
Front Endocrinol (Lausanne); 2023; 14():1127441. PubMed ID: 37223030
[TBL] [Abstract][Full Text] [Related]
63. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
64. High Expression of CHST11 Correlates with Poor Prognosis and Tumor Immune Infiltration of Pancreatic Cancer.
Zhang P; Chen D; Cui H; Luo Q
Clin Lab; 2022 Dec; 68(12):. PubMed ID: 36546737
[TBL] [Abstract][Full Text] [Related]
65. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
66. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
67. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
[TBL] [Abstract][Full Text] [Related]
68. Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer.
Chen G; Liu Y; Su D; Qiu J; Long J; Zhao F; Tao J; Yang G; Huang H; Xiao J; Zhang T; Zhao Y
Cell Oncol (Dordr); 2023 Dec; 46(6):1691-1708. PubMed ID: 37434012
[TBL] [Abstract][Full Text] [Related]
69. Identify novel inflammation-related prognostic signature in pancreatic cancer patients.
Sun Y; Zhang X; Zhu H
Medicine (Baltimore); 2024 Feb; 103(7):e36932. PubMed ID: 38363947
[TBL] [Abstract][Full Text] [Related]
70. Development of a novel senescence-related gene signature to predict clinical outcomes, immune landscape, and chemotherapeutic sensitivity in oral squamous cell carcinoma.
Wang A; Xiao N; Wang H; Yao Q; Li J; Wu Y; Ge H; Diao P
Head Neck; 2024 May; 46(5):1112-1125. PubMed ID: 38380567
[TBL] [Abstract][Full Text] [Related]
71. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
72. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis.
Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; Zong Z; Zeng B; Li Y; Zhou T
J Gastrointest Oncol; 2022 Aug; 13(4):1842-1863. PubMed ID: 36092325
[TBL] [Abstract][Full Text] [Related]
73. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
74. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
75. Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer.
Chen H; Zu F; Zeng T; Chen Z; Wei J; Liu P; Li Z; Zhou L; Wang H; Tan H; Tan X
Front Oncol; 2021; 11():757791. PubMed ID: 35127473
[TBL] [Abstract][Full Text] [Related]
76. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma.
Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C
Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729
[TBL] [Abstract][Full Text] [Related]
77. A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients.
Geng S; Fu Y; Fu S; Wu K
Front Immunol; 2022; 13():927565. PubMed ID: 36059555
[TBL] [Abstract][Full Text] [Related]
78. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
79. Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma.
Zhu ZG; Chen L; Miao DL; Jin Y; Wu Q
Front Genet; 2022; 13():941389. PubMed ID: 36046234
[No Abstract] [Full Text] [Related]
80. Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer.
Chen Y; Xu R; Ruze R; Yang J; Wang H; Song J; You L; Wang C; Zhao Y
Cancer Cell Int; 2021 Jun; 21(1):291. PubMed ID: 34090418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
